PharmaTimes -
June 2020

As part of our theme of celebrating positives in pharma and health during this difficult and turbulent time, while ensuring that we keep readers abreast of all the key developments amid the pandemic, PharmaTimes has ‘met’ with some of the next generation of leaders who are helping to secure a bright future for their companies and sectors. More on this on page 24.

Elsewhere, our cover feature (p15) looks at how pharma is rising to the challenge of ensuring a continuous supply of medicines in the wake of Brexit and the coronavirus pandemic, while Sebastian Johnson details how researchers at Oxfordshire’s unique life sciences ecosystem are leading the response to COVID-19 (p36).

Also on coronavirus, the team at Wilmington consider how it is shifting elements of the NHS Long Term Plan, outlining both the positives and negatives (p18), and we look at how the virus has hit the care of non-COVID-19 patients and the potential impact of this on death rates and economies (p7 and p42).

Finally, a reminder that the PharmaTimes Marketer of the Year, Communications Awards and Sales Awards are open for entry (visit www.pharmatimes.com/competitions for more information), while there’s also still time to enter the inaugural Patient Partnership Index (www.patientpartnershipindex.com), which closes for entry on June 23.

June 2020 - magazine highlights

Thumbnail image for Being truly patient-centric

Being truly patient-centric

PharmaTimes and OVID Health have launched the first ever Patient Partnership Index. We talk to judges Jill Pearcy, director of ABPI Code Engagement at the  Association of the British Pharmaceutical Industry, and Richard Davidson, chief executive of Sarcoma UK, about the importance of initiative and its potential impact

Thumbnail image for Chain reaction

Chain reaction

As the NHS battles to suppress the coronavirus, communities across Britain have been adjusting to a new reality. Meanwhile, pharma has taken on the task of managing, sustaining and boosting its international supply chains. The industry is, so far, rising to the challenge, creating a new template and a revised plan for the future

Thumbnail image for A double-edged sword

A double-edged sword

Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the Long Term Plan while putting others in jeopardy

Thumbnail image for Young Leaders: Helena Deus

Young Leaders: Helena Deus

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for Young Leaders: Dan Smith

Young Leaders: Dan Smith

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for Young Leaders: Mark Butcher

Young Leaders: Mark Butcher

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for Young Leaders: David Paterson

Young Leaders: David Paterson

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for Young Leaders: Emily Bottle

Young Leaders: Emily Bottle

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for Young Leaders: Andrew Wells

Young Leaders: Andrew Wells

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for Young Leaders: Fliss Barber

Young Leaders: Fliss Barber

PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future

Thumbnail image for In greener shoes

In greener shoes

Is pharma ready for the effects of the climate crisis on global health?

Thumbnail image for Safety first

Safety first

Andrew Rut on why drug safety should be top of mind during COVID-19 development

Thumbnail image for Leading the fight

Leading the fight

Oxfordshire has a unique life sciences ecosystem which has enabled it to mobilise rapidly and lead the international response to COVID-19, says Sebastian Johnson

Thumbnail image for The collapse in non-COVID care

The collapse in non-COVID care

While the NHS has focused on fighting coronavirus, care for non-COVID patients has dropped sharply. Will those patients come back?

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download